Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
RedHill Biopharma
Research
An antiviral once tested for COVID works in mice with Ebola
From cancer to COVID-19 to radiation injuries, and now Ebola: RedHill reports that opaganib appears to be effective against the virus in mice.
Helen Floersh
Oct 3, 2023 4:10pm
RedHill lightens load, abandoning phase 3 lung disease program
May 22, 2023 11:15am
RedHill slashes US commercial team by a third
Jun 23, 2022 10:37am
RedHill's COVID-19 pill prevents hospitalization in small trial
Mar 1, 2022 11:41am
2022 forecast: Bad news for dealmaking; omicron is coming
Dec 22, 2021 3:00am
RedHill follows familiar biotech path after COVID-19 drug fails
Sep 14, 2021 9:05am
